Esophageal Cancer

Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Esophageal Cancer Information Center has current, evidence-based information for you. Get the facts about esophageal cancer early detection, treatment, and survivorship, and stay up to date with ongoing esophageal cancer research that could impact your treatment decisions through our daily cancer news.

CancerConnect Esophageal Cancer Community & Discussions

You are not alone—The CancerConnect Esophageal Cancer Community is the leading Social Media Application for Esophageal Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.

ESOPHAGEAL CANCER NEWS TIPS & FEATURES

Interim PET Scans May Improve Treatment for Esophageal Cancer

February 9th, 2017

Interim PET Scans May Improve Treatment for Esophageal Cancer

Clinical trial results presented at the 2017 Gastrointestinal Cancers Symposium in San Francisco suggest that the use of PET scans to assess a cancers response […]


2016-Year in Review: Advances in Management of Gastric & Esophageal Cancer

February 4th, 2017

2016-Year in Review: Advances in Management of Gastric & Esophageal Cancer

Advances in the management of stomach (gastric), and esophageal cancer have been slow. Each year in the United States, more than 17,000 people are diagnosed […]


Proton Beam Therapy May Improve Outcomes for Esophageal Cancer

January 23rd, 2017

Proton Beam Therapy May Improve Outcomes for Esophageal Cancer

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. Radiation may be part of […]


Comprehensive Study of Esophageal Cancer Reveals Several Molecular Subtypes, Provides New Insight into Increasingly Prevalent Disease

January 16th, 2017

Comprehensive Study of Esophageal Cancer Reveals Several Molecular Subtypes, Provides New Insight into Increasingly Prevalent Disease

A comprehensive analysis of 559 esophageal and gastric cancer samples, collected from patients around the world, suggests the two main types of esophageal cancer differ […]


Should HER2 Testing Be Routinely Performed in Patients with Gastric Cancer?

December 8th, 2016

Should HER2 Testing Be Routinely Performed in Patients with Gastric Cancer?

The short answer is yes! New evidence-based guidelines for human epidermal growth factor receptor 2 (HER2) testing in advanced gastric and gastroesophageal adenocarcinoma (GEA) have […]


It's GERD Awareness Week--November 20th

November 20th, 2016

It’s GERD Awareness Week–November 20th

It’s that time of year again when there is a tendency to overindulge in a mélange of delicious foods. Although many people may only suffer […]


Another Study Confirms That Daily Aspirin Lowers Risk of Colorectal & Other GI Tract Cancers

May 9th, 2016

Another Study Confirms That Daily Aspirin Lowers Risk of Colorectal & Other GI Tract Cancers

The regular use of aspirin significantly reduces the overall risk of cancer, especially colorectal and other gastrointestinal tract cancers, according to a study published in JAMA Oncology.1 The […]


Pass It On: April is Esophageal Cancer Awareness Month

April 18th, 2016

Pass It On: April is Esophageal Cancer Awareness Month

As the month of April brings esophageal cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening […]


Another Reason to Break the Habit: Smoking Alters Bacterial Balance in Mouth

April 12th, 2016

Another Reason to Break the Habit: Smoking Alters Bacterial Balance in Mouth

Smoking drastically alters the oral microbiome, the mix of roughly 600 bacterial species that live in people’s mouths. This is the finding of a study […]


Vistogard® Approved for Life-Threatening Toxicities of Certain Chemotherapy Agents

February 11th, 2016

Vistogard® Approved for Life-Threatening Toxicities of Certain Chemotherapy Agents

The United States Food and Drug Administration (FDA) approved Vistogard (uridine triacetate) for the treatment of life-threatening toxicities caused by the chemotherapy drugs fluorouracil or […]


More News →